ABThera™ Open Abdomen Negative Pressure Therapy


IMPORTANT: The information contained on this page and in the videos, links and content posted is intended only for healthcare professionals.  If you are a patient viewing this site, you should consult with your healthcare professional providers regarding your specific medical conditions and treatments as well as the information provided on this page, including the risks and benefits of certain products and services that may be discussed on this page.

The ABThera Open Abdomen (OA) Negative Pressure Therapy (NPT) System provides continuous negative pressure to remove high volumes of exudate.  This temporary abdominal closure (TAC) system enables healthcare professionals to take control early in the management of challenging open abdomens, helping to achieve primary fascial closure.

The ABThera OA NPT System

  • • Actively removes fluid and infectious material from the abdomen, helping to reduce edema
  • • Draws wound edges together, providing medial tension, which helps minimize fascial retraction and loss of domain1
  • • Helps isolate viscera and abdominal contents from external environment
  • • Provides separation between the abdominal wall and viscera, protecting abdominal contents
  • • Allows rapid access for re-entry and does not require sutures for placement

Visceral Protective Layer

  • • Facilitates removal of fluid from paracolic gutters
  • • Provides separation between abdominal wall and viscera, protecting abdominal contents
  • • Designed for easy handling and rapid application
  • • Allows rapid access for re-entry
  • • No sutures required for placement, minimizing fascial damage

1Miller Pr, et al. Prospective evaluation of vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate is substantially reduced. Ann Surg. 2004 May; 239(5):608-614.

Watch and learn as trauma surgeon, Mark Kaplan demonstrates how ABThera™ Therapy works.

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Please consult a physician and product instructions for use prior to application. Rx only.

KCI e-labeling site.

©2012 KCI Licensing, Inc. All rights reserved. All trademarks designated herein are proprietary to KCI Licensing, Inc., its affiliates and/or licensors. DSL#12-0315.US (11/12)



Mark J. Kaplan

Mark J. Kaplan, MD, FACS

Chief of Trauma & Surgical Critical Care